Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031

PHASE1TerminatedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy
Interventions
DRUG

DWP09031

DWP09031 50mg/100mg/400mg/200mg/800mg/1200mg/1600mg/2000mg single dosing

DRUG

Placebo

placebo comparator 50mg/100mg/400mg/200mg/800mg/1200mg/1600mg/2000mg single dosing

Trial Locations (1)

614-735

Inje University College of Medicine Busan Paik Hospital, Busan

All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY